GlassScriptPhysician profile
Yanis Bellil
NPI 1164566550
$6,170.63
in general payments reported to CMS, 2019-2025
60 companies · $1,881 in 2025
The $1,881 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $133 · 2021: $263 · 2022: $884 · 2023: $1,328 · 2024: $1,484 · 2025: $1,881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,694.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $886.48 | 2019-2025 | |
| Gilead Sciences, INC. | $474.25 | 2021-2025 | Trodelvy |
| Daiichi Sankyo INC. | $400.46 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Celgene Corporation | $268.44 | 2022-2025 | Reblozyl, Pomalyst |
| E.R. Squibb & Sons, L.L.C. | $266.29 | 2019-2025 | Opdivo, Eliquis |
| Astrazeneca Pharmaceuticals LP | $246.27 | 2020-2025 | Enhertu, Lynparza, Calquence |
| Pfizer INC. | $236.17 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $220.20 | 2019-2025 | Keytruda, Lynparza |
| Amgen INC. | $199.62 | 2019-2023 | Kyprolis, Blincyto |
| Janssen Biotech, INC. | $157.78 | 2019-2025 | Balversa, Erleada, Akeega |
| Glaxosmithkline, LLC. | $154.04 | 2022-2025 | Ojjaara, Blenrep, Jemperli |
| Genzyme Corporation | $145.72 | 2021-2024 | |
| Jazz Pharmaceuticals INC. | $134.70 | 2023-2025 | |
| Abbvie INC. | $133.08 | 2021-2025 | Venclexta |
| Lilly USA, LLC | $132.58 | 2022-2024 | Verzenio, Jaypirca |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $120.23 | 2022-2025 | Bavencio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.06 | 2021-2025 | |
| Incyte Corporation | $93.81 | 2023-2025 | Jakafi, Pemazyre, Monjuvi |
| Beone Medicines USA, INC. | $86.28 | 2025 | Brukinsa |
| Ipsen Biopharmaceuticals, INC | $83.37 | 2020-2025 | Onivyde, Somatuline Depot |
| Array Biopharma INC | $78.61 | 2024-2025 | Lorbrena, Braftovi, Mektovi |
| Karyopharm Therapeutics INC. | $75.28 | 2020-2025 | Xpovio |
| Rigel Pharmaceuticals, INC. | $71.04 | 2023-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Takeda Pharmaceuticals U.S.A., INC. | $69.13 | 2023-2024 | Iclusig, Exkivity, Fruzaqla |
| Alnylam Pharmaceuticals INC. | $67.69 | 2022-2025 | Givlaari |
| Regeneron Healthcare Solutions, INC. | $66.32 | 2021-2025 | Libtayo |
| Sobi, INC | $60.30 | 2023-2025 | |
| Tersera Therapeutics LLC | $57.78 | 2022-2025 | Xermelo, Quzyttir |
| Integra Lifesciences Corporation | $50.34 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Eisai INC. | $50.24 | 2022-2025 | |
| Puma Biotechnology, INC. | $50.08 | 2023-2024 | |
| Seagen INC. | $49.55 | 2022-2023 | Tukysa |
| Genentech USA, INC. | $48.86 | 2019-2024 | Itovebi, Phesgo |
| Spectrum Pharmaceuticals INC. | $46.44 | 2025 | Rolvedon |
| Bayer Healthcare Pharmaceuticals INC. | $46.10 | 2023 | |
| Alexion Pharmaceuticals, INC. | $45.58 | 2021-2025 | Ultomiris |
| Beigene USA, INC. | $45.23 | 2024-2025 | Brukinsa |
| Astellas Pharma US INC | $45.01 | 2024-2025 | Vyloy, Padcev |
| Adc Therapeutics America, INC. | $42.85 | 2025 | |
| Blue Earth Diagnostics | $41.88 | 2021-2022 | |
| Medtronic, INC. | $40.08 | 2023 | Osteocool Rf Ablation System |
| Pharmacosmos Therapeutics INC. | $35.17 | 2023-2024 | Cosela, Monoferric |
| Kite Pharma, INC. | $34.42 | 2022 | |
| Servier Pharmaceuticals LLC | $34.36 | 2023 | |
| Pharmaand Gmbh | $33.84 | 2025 | Rubraca |
| Tolmar, INC. | $33.84 | 2025 | Rubraca, Eligard |
| Kyowa Kirin, INC. | $31.89 | 2019-2025 | |
| Invivyd INC | $28.21 | 2025 | Pemgarda |
| Emmaus Medical, INC. | $27.91 | 2022 | |
| Tempus Ai, INC | $27.05 | 2024 | Xt Cdx |
| Adaptive Biotechnologies Corporation | $24.52 | 2022 | |
| Springworks Therapeutics, INC. | $24.19 | 2025 | Ogsiveo |
| Deciphera Pharmaceuticals INC. | $23.59 | 2024 | Qinlock |
| Stemline Therapeutics INC. | $22.78 | 2023 | Orserdu |
| Shield Therapeutics INC | $21.40 | 2024 | |
| Menarini Silicon Biosystems, INC. | $20.05 | 2023 | Cellsearch |
| Mirati Therapeutics, INC. | $18.54 | 2023 | Krazati |
| G1 Therapeutics, INC. | $16.66 | 2023 | Cosela |
| Morphosys, US INC. | $15.83 | 2022 | |
| Myovant Sciences INC. | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yanis Bellil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.